TriNetX Founder Gadi Lachman Announced His Upcoming Resignation After Eleven Years of Leadership
TriNetX, recognized as the largest global source of real-world data, has made a significant announcement regarding a change in its leadership. Gadi Lachman, who founded the company in 2014 and has served as its President and CEO since, is slated to depart from his operational role at the end of March 2025. Although he will step down from day-to-day management, Lachman will remain a member of the board of directors and will provide advisory support to Carlyle, TriNetX's majority investor.
Expressing his heartfelt gratitude, Lachman stated, "It has been an honor to create TriNetX and be part of such an exceptional team. I want to thank the employees, customers, and shareholders of TriNetX for their unwavering support. With the talent and passion of our people, I have immense confidence in the continued success of TriNetX." He highlighted the company’s journey in establishing a substantial global platform for clinical research, accumulating data from over 25 countries and facilitating millions of queries monthly. The solutions provided by TriNetX, he emphasized, have the potential to elevate clinical research to new heights, ultimately saving lives across various therapeutic areas.
In anticipation of a smooth leadership transition, Jeff Margolis, the current director of TriNetX, has been appointed as the Executive Chairman. He will ensure continuity in leadership and governance during the search for a new CEO. Margolis expressed his privilege of working alongside Lachman over the years and thanked him for shaping TriNetX into a premier ecosystem of real-world data and evidence serving the life sciences and healthcare industries.
Joe Bress, partner and global co-head of Healthcare at Carlyle, also shared his thoughts on Lachman's leadership. He acknowledged that TriNetX has maintained profitability even during periods of rapid growth, a testament to Lachman's disciplined guidance. Bress remarked that the company is positioned for an exciting future, ready for new leadership to navigate the next chapter of its growth.
Looking forward, TriNetX remains steadfast in its mission to enhance global healthcare through the power of real-world data. The board of directors, leadership team, and employees are all committed to fostering continuous innovation and achieving success for clients and partners, all while building on Lachman's exceptional legacy.
TriNetX is a global network of healthcare organizations and life sciences companies dedicated to advancing real-world research and accelerating the development of new therapies. Through its HIPAA, GDPR, and LGPD-compliant self-service platform that federates de-identified electronic health record data and consulting partnerships, TriNetX empowers its global community to improve the design of clinical trial protocols, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, visit TriNetX at www.trinetx.com or follow them on LinkedIn.
Expressing his heartfelt gratitude, Lachman stated, "It has been an honor to create TriNetX and be part of such an exceptional team. I want to thank the employees, customers, and shareholders of TriNetX for their unwavering support. With the talent and passion of our people, I have immense confidence in the continued success of TriNetX." He highlighted the company’s journey in establishing a substantial global platform for clinical research, accumulating data from over 25 countries and facilitating millions of queries monthly. The solutions provided by TriNetX, he emphasized, have the potential to elevate clinical research to new heights, ultimately saving lives across various therapeutic areas.
In anticipation of a smooth leadership transition, Jeff Margolis, the current director of TriNetX, has been appointed as the Executive Chairman. He will ensure continuity in leadership and governance during the search for a new CEO. Margolis expressed his privilege of working alongside Lachman over the years and thanked him for shaping TriNetX into a premier ecosystem of real-world data and evidence serving the life sciences and healthcare industries.
Joe Bress, partner and global co-head of Healthcare at Carlyle, also shared his thoughts on Lachman's leadership. He acknowledged that TriNetX has maintained profitability even during periods of rapid growth, a testament to Lachman's disciplined guidance. Bress remarked that the company is positioned for an exciting future, ready for new leadership to navigate the next chapter of its growth.
Looking forward, TriNetX remains steadfast in its mission to enhance global healthcare through the power of real-world data. The board of directors, leadership team, and employees are all committed to fostering continuous innovation and achieving success for clients and partners, all while building on Lachman's exceptional legacy.
About TriNetX, LLC
TriNetX is a global network of healthcare organizations and life sciences companies dedicated to advancing real-world research and accelerating the development of new therapies. Through its HIPAA, GDPR, and LGPD-compliant self-service platform that federates de-identified electronic health record data and consulting partnerships, TriNetX empowers its global community to improve the design of clinical trial protocols, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, visit TriNetX at www.trinetx.com or follow them on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.